{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:54:41Z","timestamp":1789595681596,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastric cancer (GC) is the 5<jats:sup>th<\/jats:sup> most prevalent cancer and the 4<jats:sup>th<\/jats:sup> primary cancer-associated mortality globally. As the first identified m6A demethylase for removing RNA methylation modification, fat mass and <jats:italic>obesity-associated protein<\/jats:italic> (<jats:italic>FTO<\/jats:italic>) plays instrumental roles in cancer development. Therefore, we study the biological functions and oncogenic mechanisms of <jats:italic>FTO<\/jats:italic> in GC tumorigenesis and progression. In our study, <jats:italic>FTO<\/jats:italic> expression is obviously upregulated in GC tissues and cells. The upregulation of <jats:italic>FTO<\/jats:italic> is associated with advanced nerve invasion, tumor size, and LNM, as well as the poor prognosis in GC patients, and promoted GC cell viability, colony formation, migration and invasion. Mechanistically, <jats:italic>FTO<\/jats:italic> targeted specificity protein 1 and Aurora Kinase B, resulting in the phosphorylation of ataxia telangiectasia mutated and P38 and dephosphorylation of P53. In conclusion, the m6A demethylase <jats:italic>FTO<\/jats:italic> promotes GC tumorigenesis and progression by regulating the SP1-AURKB-ATM pathway, which may highlight the potential of <jats:italic>FTO<\/jats:italic> as a diagnostic biomarker for GC patients\u2019 therapy response and prognosis.<\/jats:p>","DOI":"10.1038\/s42003-024-06477-y","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:26:03Z","timestamp":1719933963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["RNA demethylase FTO participates in malignant progression of gastric cancer by regulating SP1-AURKB-ATM pathway"],"prefix":"10.1038","volume":"7","author":[{"given":"Xueliang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taohui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-0193","authenticated-orcid":false,"given":"Bei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-177X","authenticated-orcid":false,"given":"Hulai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"6477_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C. & Lordick, F. Gastric cancer. Lancet 396, 635\u2013648 (2020).","journal-title":"Lancet"},{"key":"6477_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"6477_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"6477_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift, A. P. & El-Serag, H. B. Burden of gastric cancer. Clin. Gastroenterol. Hepatol. 18, 534\u2013542 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"6477_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri, I. & Kouzarides, T. Role of RNA modifications in cancer. Nat. Rev. Cancer 20, 303\u2013322 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"6477_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He, L. et al. Functions of N6-methyladenosine and its role in cancer. Mol. Cancer 18, 176 (2019).","journal-title":"Mol. Cancer"},{"key":"6477_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol. Cancer 21, 32 (2022).","journal-title":"Mol. Cancer"},{"key":"6477_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1065-4","volume":"18","author":"B Yue","year":"2019","unstructured":"Yue, B. et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol. Cancer 18, 142 (2019).","journal-title":"Mol. Cancer"},{"key":"6477_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41419-022-04503-7","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m(6)A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics. Cell Death Dis. 13, 72 (2022).","journal-title":"Cell Death Dis."},{"key":"6477_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01522-y","volume":"21","author":"Y Hu","year":"2022","unstructured":"Hu, Y. et al. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Mol. Cancer 21, 34 (2022).","journal-title":"Mol. Cancer"},{"key":"6477_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01521-z","volume":"21","author":"HN Fan","year":"2022","unstructured":"Fan, H. N. et al. METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p\/AKT1S1 axis. Mol. Cancer 21, 51 (2022).","journal-title":"Mol. Cancer"},{"key":"6477_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia, G. et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885\u2013887 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"6477_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","volume":"41","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J. Exp. Clin. Cancer Res. 41, 42 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"6477_CR14","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/cr.2014.151","volume":"24","author":"X Zhao","year":"2014","unstructured":"Zhao, X. et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 24, 1403\u20131419 (2014).","journal-title":"Cell Res."},{"key":"6477_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41416-021-01581-w","volume":"126","author":"T Shimura","year":"2022","unstructured":"Shimura, T. et al. Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer. Br. J. cancer 126, 228\u2013237 (2022).","journal-title":"Br. J. cancer"},{"key":"6477_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jcp.1111","volume":"188","author":"AR Black","year":"2001","unstructured":"Black, A. R., Black, J. D. & Azizkhan-Clifford, J. Sp1 and kr\u00fcppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188, 143\u2013160 (2001).","journal-title":"J. Cell. Physiol."},{"key":"6477_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/cpr.12292","volume":"49","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Sp1 transcription factor promotes TMEPAI gene expression and contributes to cell proliferation. Cell Prolif. 49, 710\u2013719 (2016).","journal-title":"Cell Prolif."},{"key":"6477_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110068","volume":"85","author":"X Dong","year":"2021","unstructured":"Dong, X. et al. USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma. Cell. Signal. 85, 110068 (2021).","journal-title":"Cell. Signal."},{"key":"6477_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41418-021-00879-9","volume":"29","author":"HT Liu","year":"2022","unstructured":"Liu, H. T. et al. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus. Cell Death Differ. 29, 627\u2013641 (2022).","journal-title":"Cell Death Differ."},{"key":"6477_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41417-018-0048-8","volume":"25","author":"X Han","year":"2018","unstructured":"Han, X., Zhang, J. J., Han, Z. Q., Zhang, H. B. & Wang, Z. A. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB. Cancer Gene Ther. 25, 300\u2013308 (2018).","journal-title":"Cancer Gene Ther."},{"key":"6477_CR21","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","volume":"15","author":"M Choi","year":"2016","unstructured":"Choi, M., Kipps, T. & Kurzrock, R. ATM mutations in cancer: therapeutic implications. Mol. Cancer Therap. 15, 1781\u20131791 (2016).","journal-title":"Mol. Cancer Therap."},{"key":"6477_CR22","first-page":"842","volume":"55","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. The FBXO32\/ATR\/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression. Acta Biochim. Biophys. Sin. 55, 842\u2013852 (2023).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"6477_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.molcel.2011.09.016","volume":"44","author":"C Yang","year":"2011","unstructured":"Yang, C. et al. Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint. Mol. Cell 44, 597\u2013608 (2011).","journal-title":"Mol. Cell"},{"key":"6477_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01322-w","volume":"20","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer. Mol. Cancer 20, 29 (2021).","journal-title":"Mol. Cancer"},{"key":"6477_CR25","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","volume":"160","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 axis and is a therapeutic target. Gastroenterology 160, 1284\u20131300.e1216 (2021).","journal-title":"Gastroenterology"},{"key":"6477_CR26","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3390\/ijms23073800","volume":"23","author":"SK Azzam","year":"2022","unstructured":"Azzam, S. K., Alsafar, H. & Sajini, A. A. FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms. Int. J. Mol. Sci. 23, 3800 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"6477_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21758-4","volume":"12","author":"S Relier","year":"2021","unstructured":"Relier, S. et al. FTO-mediated cytoplasmic m(6)A(m) demethylation adjusts stem-like properties in colorectal cancer cell. Nat. Commun. 12, 1716 (2021).","journal-title":"Nat. Commun."},{"key":"6477_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12032-014-0329-5","volume":"32","author":"R Leng","year":"2015","unstructured":"Leng, R., Liao, G., Wang, H., Kuang, J. & Tang, L. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome. Med. Oncol. 32, 329 (2015).","journal-title":"Med. Oncol."},{"key":"6477_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10911-010-9178-9","volume":"15","author":"DS Micalizzi","year":"2010","unstructured":"Micalizzi, D. S., Farabaugh, S. M. & Ford, H. L. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol. Neoplasia 15, 117\u2013134 (2010).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"6477_CR30","first-page":"5609","volume":"7","author":"XM Ma","year":"2014","unstructured":"Ma, X. M. et al. Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression. Int. J. Clin. Exp. Pathol. 7, 5609\u20135621 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"6477_CR31","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.3892\/mmr.2016.4972","volume":"13","author":"W Zhao","year":"2016","unstructured":"Zhao, W., Lu, M. & Zhang, Q. Chloride intracellular channel 1 regulates migration and invasion in gastric cancer by triggering the ROS-mediated p38 MAPK signaling pathway. Mol. Med. Rep. 13, 3711 (2016).","journal-title":"Mol. Med. Rep."},{"key":"6477_CR32","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1002\/cam4.2360","volume":"8","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Reduced m6A modification predicts malignant phenotypes and augmented Wnt\/PI3K-Akt signaling in gastric cancer. Cancer Med. 8, 4766\u20134781 (2019).","journal-title":"Cancer Med."},{"key":"6477_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107534","volume":"26","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. Inhibition of FNDC1 suppresses gastric cancer progression by interfering with G\u03b2\u03b3-VEGFR2 complex formation. iScience 26, 107534 (2023).","journal-title":"iScience"},{"key":"6477_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/sjg.SJG_283_18","volume":"25","author":"LV Wangxia","year":"2019","unstructured":"Wangxia, L. V. et al. Circular RNA ARHGAP26 is over-expressed and its downregulation inhibits cell proliferation and promotes cell apoptosis in gastric cancer cells. Saudi J. Gastroenterol. 25, 119\u2013125, (2019).","journal-title":"Saudi J. Gastroenterol."},{"key":"6477_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13046-022-02466-3","volume":"41","author":"Q Ma","year":"2022","unstructured":"Ma, Q. et al. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex. J. Exp. Clin. Cancer Res. 41, 251 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"6477_CR36","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.7150\/thno.43150","volume":"10","author":"P Huang","year":"2020","unstructured":"Huang, P. et al. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer. Theranostics 10, 4644\u20134658 (2020).","journal-title":"Theranostics"},{"key":"6477_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101289","volume":"16","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Chondrocyte-derived exosomal miR-195 inhibits osteosarcoma cell proliferation and anti-apoptotic by targeting KIF4A in vitro and in vivo. Transl. Oncol. 16, 101289 (2022).","journal-title":"Transl. Oncol."},{"key":"6477_CR38","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00432-014-1858-1","volume":"141","author":"K Wang","year":"2015","unstructured":"Wang, K. et al. Prognostic significance of SERPINE2 in gastric cancer and its biological function in SGC7901 cells. J. Cancer Res. Clin. Oncol. 141, 805\u2013812 (2015).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"6477_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100936","volume":"68","author":"X Qu","year":"2023","unstructured":"Qu, X. et al. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer. Drug Resist Updat 68, 100936 (2023).","journal-title":"Drug Resist Updat"},{"key":"6477_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13046-020-01620-z","volume":"39","author":"JZ Liu","year":"2020","unstructured":"Liu, J. Z. et al. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer. J. Exp. Clin. Cancer Res. 39, 123 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"6477_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40880-018-0315-y","volume":"38","author":"F Du","year":"2018","unstructured":"Du, F. et al. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun. 38, 45 (2018).","journal-title":"Cancer Commun."},{"key":"6477_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li, D. et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene 42, 83\u201398 (2023).","journal-title":"Oncogene"},{"key":"6477_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2021.10.001","volume":"37","author":"H Yang","year":"2022","unstructured":"Yang, H. et al. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. J. Adv. Res. 37, 91\u2013106 (2022).","journal-title":"J. Adv. Res."},{"key":"6477_CR44","doi-asserted-by":"publisher","first-page":"10666","DOI":"10.1073\/pnas.1611481113","volume":"113","author":"XF Liu","year":"2016","unstructured":"Liu, X. F. et al. Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis. Proc. Natl Acad. Sci. USA 113, 10666\u201310671 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6477_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13046-022-02449-4","volume":"41","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun\/c-Fos\/SREBP1 axis in gastric cancer. J. Exp. Clin. Cancer Res. 41, 287 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"6477_CR46","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.pathol.2020.10.015","volume":"53","author":"SW Kim","year":"2021","unstructured":"Kim, S. W., Jeong, G., Ryu, M. H. & Park, Y. S. Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens. Pathology 53, 586\u2013594 (2021).","journal-title":"Pathology"},{"key":"6477_CR47","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1038\/s41388-021-01838-x","volume":"40","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K\/AKT signaling. Oncogene 40, 6666\u20136679 (2021).","journal-title":"Oncogene"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06477-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06477-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06477-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T01:05:03Z","timestamp":1719968703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06477-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6477"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06477-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"800"}}